Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome

Simplified assessment of segmental colonic transit

Metcalf, A. M., Phillips, S. F., Zinsmeister, A. R., MacCarty, R. L., Beart, R. W., & Wolff, B. G. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90837-7 · Cited by 928 · see citing works

Capacity of the human colon to absorb fluid

Debongnie, J. C., & Phillips, S. F. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90246-9 · Cited by 416 · see citing works

Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns.

Cann, P. A., Read, N. W., Brown, C., Hobson, N., & Holdsworth, C. D. (1983) · Gut · doi:10.1136/gut.24.5.405 · Cited by 365 · see citing works

5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine

Grider, J. R., Foxx–Orenstein, A. E., & Jin, J. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70203-3 · Cited by 349 · see citing works

Bran and irritable bowel syndrome: time for reappraisal

Francis, C. Y. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91055-3 · Cited by 315 · see citing works

Scintigraphic measurement of regional gut transit in idiopathic constipation.

Stivland, T., Camilleri, M., Vassallo, M., Proano, M., Rath, D. M., Brown, M. L., Thomforde, G., Pemberton, J., & Phillips, S. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90466-x · Cited by 272 · see citing works

Cisapride

Wiseman, L. R., & Faulds, D. M. (1994) · Drugs · doi:10.2165/00003495-199447010-00008 · Cited by 243 · see citing works

Human gastric emptying and colonic filling of solids characterized by a new method

Camilleri, M., Colemont, L. J., Phillips, S. F., Brown, M. L., Thomforde, G. M., Chapman, N., & Zinsmeister, A. R. (1989) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1989.257.2.g284 · Cited by 227 · see citing works

Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans

Bouras, E. P., Camilleri, M., Burton, D., & Mckinzie, S. (1999) · Gut · doi:10.1136/gut.44.5.682 · Cited by 225 · see citing works

Towards a less costly but accurate test of gastric emptying and small bowel transit

Camilleri, M., Zinsmeister, A. R., Greydanus, M. P., Brown, M. L., & Proano, M. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01297027 · Cited by 198 · see citing works

The Irritable Bowel Syndrome: Mechanisms and a Practical Approach to Management

Camilleri, M., & Prather, C. M. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-12-1001 · Cited by 131 · see citing works

Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders.

Camilleri, M., & Zinsmeister, A. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91092-i · Cited by 129 · see citing works

Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets.

Burton, D. D., Camilleri, M., Mullan, B. P., Forstrom, L. A., & HUNG, J. C. (1997) · PubMed · Cited by 115 · see citing works

Scintigraphy of the whole gut: clinical evaluation of transit disorders.

Charles, F., Camilleri, M., Phillips, S. F., Thomforde, G., & Forstrom, L. A. (1995) · Mayo Clinic proceedings · doi:10.4065/70.2.113 · Cited by 111 · see citing works

“Prokinetic” Treatment of Constipation-Predominant Irritable Bowel Syndrome

Outryve, M. V., Milo, R., Toussaint, J., & Eeghem, P. V. (1991) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199102000-00012 · Cited by 95 · see citing works

SDZ HTF 919 Stimulates Canine Colonic Motility and Transit In Vivo

Nguyen, A., Camilleri, M., Kost, L. J., Metzger, A., Sarr, M. G., Hanson, R. B., Fett, S. L., & Zinsmeister, A. R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36528-0 · Cited by 94 · see citing works

Fluid loading of the human colon: effects on segmental transit and stool composition.

Hammer, J., & Phillips, S. F. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90941-5 · Cited by 79 · see citing works

First Pharmacokinetic—Pharmacodynamic Study in Humans with a Selective 5‐Hydroxytryptamine4 Receptor Agonist

Appel, S., Kumle, A., Hubert, M., & Duvauchelle, T. (1997) · Journal of clinical pharmacology · doi:10.1002/j.1552-4604.1997.tb04785.x · Cited by 73 · see citing works

Clinical pharmacodynamics of SDZ HTF 919, a new 5‐HT4 receptor agonist, in a model of slow colonic transit

Appel, S., Kumle, A., & Meier, R. (1997) · Clinical pharmacology and therapy · doi:10.1016/s0009-9236(97)90050-3 · Cited by 38 · see citing works

Investigation into the effect of 5-hydroxytryptamine on fluid transport in the rat small intestine

McLean, P. G., & Coupar, I. M. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)00095-5 · Cited by 18 · see citing works

High Affinity of SDZ HTF‐919 and Related Molecules for Calf and Human Caudate 5‐HT4 Receptors

Hoyer, D., Fehlmann, D., Langenegger, D., KUMMER, J., Giger, R., Mattes, H., Probst, A., & Pfannkuche, H. ‐. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10217.x · Cited by 13 · see citing works

In vivo modulation of left colonic motor function by a 5HT4 mechanism in healthy humans

von der Ohe, M. R., Klingenburg, S., & Goebel, H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)83488-4 · Cited by 3 · see citing works

Bowel Disorders

Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866 · see citing works

The serotonin signaling system: from basic understanding to drug development for functional GI disorders

Gershon, M. D., & Tack, J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.002 · Cited by 1,563 · see citing works

Postinfectious Irritable Bowel Syndrome

Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024 · see citing works

ACG Clinical Guideline: Management of Irritable Bowel Syndrome

Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001036 · Cited by 893 · see citing works

American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis

Parkman, H. P., Hasler, W. L., & Fisher, R. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.055 · Cited by 738 · see citing works

American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

Ford, A. C., Moayyedi, P., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E., Spiegel, B. M. R., & Quigley, E. M. M. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.187 · Cited by 648 · see citing works

5-Hydroxytryptamine (serotonin) in the gastrointestinal tract

Gershon, M. D. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32835bc703 · Cited by 617 · see citing works

British Society of Gastroenterology guidelines on the management of irritable bowel syndrome

Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 547 · see citing works

Review article: serotonin receptors and transporters — roles in normal and abnormal gastrointestinal motility

Gershon, M. D. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02180.x · Cited by 521 · see citing works

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea‐predominant irritable bowel syndrome

Kim, H. J., Camilleri, M., Mckinzie, S., Lempke, M. B., Burton, D. D., Thomforde, G. M., & Zinsmeister, A. R. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01543.x · Cited by 468 · see citing works

Tegaserod, a 5‐HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

Müller-Lissner, S. A., Fumagalli, I. A. L., Bardhan, K. D., Pace, F., Pecher, E., Nault, B., & Rüegg, P. C. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01094.x · Cited by 462 · see citing works

Serotonin: A Mediator of The Brain–Gut Connection

Kim, D.-Y., & Camilleri, M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03177.x · Cited by 448 · see citing works

Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies

Rao, S. S. C., Camilleri, M., Hasler, W. L., Maurer, A. H., Parkman, H. P., Saad, R., Scott, S. M., Simrén, M., Soffer, E., & Szarka, L. A. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01612.x · Cited by 381 · see citing works

Treatment of gastroparesis: a multidisciplinary clinical review: The American Motility Society Task Force on Gastroparesis (members in alphabetical order)

Abell, T. L., Bernstein, V. K., Cutts, T., Farrugia, G., Forster, J., Hasler, W. L., Mccallum, R. W., Olden, K. W., Parkman, H. P., Parrish, C. R., et al. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00760.x · Cited by 361 · see citing works

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

Dunlop, S. P., Coleman, N. S., Blackshaw, E., Perkins, A. C., Singh, G., Marsden, C. A., & Spiller, R. E. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00726-8 · Cited by 355 · see citing works

Postinfectious irritable bowel syndrome1 1Abbreviations used in this paper: EC,_; IBS, irritable bowel syndrome; PI, postinfective.

Spiller, R. E. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00324-x · Cited by 353 · see citing works

Systematic Review on the Management of Chronic Constipation in North America

Brandt, L. J., Prather, C. M., Quigley, E. M. M., Schiller, L. R., Schoenfeld, P., & Talley, N. J. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.50613_2.x · Cited by 342 · see citing works

Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation

Johanson, J. F., Morton, D., Geenen, J., & Ueno, R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01524.x · Cited by 331 · see citing works

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder.

Bouras, E. P., Camilleri, M., Burton, D., Thomforde, G., Mckinzie, S., & Zinsmeister, A. (2001) · Gastroenterology · doi:10.1053/gast.2001.21166 · Cited by 306 · see citing works

Role of serotonin in the pathophysiology of the irritable bowel syndrome

Crowell, M. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705762 · Cited by 289 · see citing works

A randomized, double‐blind, placebo‐controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

Novick, J. S., Miner, P. B., Krause, R. A., Glebas, K., Bliesath, H., Ligozio, G., Rüegg, P. C., & Lefkowitz, M. P. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01372.x · Cited by 288 · see citing works

Physiological Modulation of Intestinal Motility by Enteric Dopaminergic Neurons and the D2 Receptor: Analysis of Dopamine Receptor Expression, Location, Development, and Function in Wild-Type and Knock-Out Mice

Li, Z., Schmauss, C., Cuenca, A., Ratcliffe, E., & Gershon, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4720-05.2006 · Cited by 262 · see citing works

Nerves, Reflexes, and the Enteric Nervous System: Pathogenesis of the Irritable Bowel Syndrome

Gershon, M. D. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000156403.37240.30 · Cited by 271 · see citing works

Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers

Camilleri, M., Bharucha, A. E., Ueno, R., Burton, D., Thomforde, G. M., Baxter, K., McKinzie, S., & Zinsmeister, A. R. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00264.2005 · Cited by 253 · see citing works

Neurohumoral control of gastrointestinal motility

Hansen, M. (2003) · Physiological Research · doi:10.33549/physiolres.930255 · Cited by 246 · see citing works

Effect of 5 Days Linaclotide on Transit and Bowel Function in Females With Constipation-Predominant Irritable Bowel Syndrome

Andresen, V., Camilleri, M., Busciglio, I. A., Grudell, A., Burton, D. D., McKinzie, S., Foxx–Orenstein, A. E., Kurtz, C. B., Sharma, V., Johnston, J. M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.067 · Cited by 245 · see citing works

Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome

Camilleri, M., McKinzie, S., Busciglio, I. A., Low, P. A., Sweetser, S. R., Burton, D. D., Baxter, K. L., Ryks, M. D., & Zinsmeister, A. R. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.060 · Cited by 242 · see citing works

The Irritable Bowel Syndrome

Horwitz, B. J., & Fisher, R. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106143442407 · Cited by 235 · see citing works

Serotonin and GI clinical disorders

Spiller, R. E. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.016 · Cited by 234 · see citing works

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

Kellow, J. E., Lee, O. Y., Chang, F. Y., Thongsawat, S., Mazlam, M. Z., Yuen, H., Gwee, K., Bak, Y., Jones, J., & Wagner, A. (2003) · Gut · doi:10.1136/gut.52.5.671 · Cited by 230 · see citing works

Meta‐analysis: the treatment of irritable bowel syndrome

Pantoflickova, D., Michetti, P., Fried, M., Beglinger, C., & Blum, A. L. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02267.x · Cited by 222 · see citing works

Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome

Matricon, J., Méleine, M., Gelot, A., Piche, T., Dapoigny, M. C., Muller, E., & Ardid, D. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12080 · Cited by 216 · see citing works

Tegaserod, a 5‐HT 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects

Degen, L. P., Matzinger, D., Merz, M., Appel‐Dingemanse, S., Osborne, S., Lüchinger, S., Bertold, R., Maëcke, H. R., & Beglinger, C. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01103.x · Cited by 211 · see citing works

Irritable Bowel Syndrome

Mertz, H. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035579 · Cited by 206 · see citing works

Health-Related Quality of Life and Cost Impact of Irritable Bowel Syndrome in a UK Primary Care Setting

Akehurst, R. L., Brazier, J. E., Mathers, N. J., Keefe, C. O., Kaltenthaler, E., Morgan, A., Platts, M., & Walters, S. J. (2002) · PharmacoEconomics · doi:10.2165/00019053-200220070-00003 · Cited by 203 · see citing works

Tegaserod

Camilleri, M. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00925.x · Cited by 198 · see citing works

Tegaserod for the Treatment of Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Multinational Study

Kamm, M. A., Müller-Lissner, S. A., Talley, N. J., Tack, J. F., Boeckxstaens, G. E., Minushkin, O. N., Калинин, А. А., Dzieniszewski, J., van der Haeck, P. W. E., Fordham, F., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40749.x · Cited by 193 · see citing works

Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma)

Sallam, H. S., McNearney, T. A., & Chen, J. D. Z. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02804.x · Cited by 190 · see citing works

Performance characteristics of scintigraphic transit measurements for studies of experimental therapies

Cremonini, F., Mullan, B. P., Camilleri, M., Burton, D. D., & Rank, M. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01344.x · Cited by 183 · see citing works

Serotoninergic neuroenteric modulators

Talley, N. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07103-3 · Cited by 178 · see citing works

Effect of tegaserod in chronic constipation: A randomized, double-blind, controlled trial

Johanson, J. F., Wald, A. M., Tougas, G. H., Chey, W. D., Novick, J. S., Lembo, A. J., Fordham, F., Guella, M., & Nault, B. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00356-8 · Cited by 175 · see citing works

Gastroparesis: Current diagnostic challenges and management considerations

Waseem, S., Moshiree, B., & Draganov, P. V. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.15.25 · Cited by 177 · see citing works

Postoperative Ileus and Postoperative Gastrointestinal Tract Dysfunction: Pathogenic Mechanisms and Novel Treatment Strategies Beyond Colorectal Enhanced Recovery After Surgery Protocols

Mazzotta, E. A., Villalobos-Hernández, E. C., Fiorda‐Diaz, J., Harzman, A. E., & Christofi, F. L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.583422 · Cited by 177 · see citing works

Colonic transit studies: normal values for adults and children with comparison of radiological and scintigraphic methods

Southwell, B. R., Clarke, M. C. C., Sutcliffe, J. R., & Hutson, J. M. (2009) · Pediatric Surgery International · doi:10.1007/s00383-009-2387-x · Cited by 165 · see citing works

Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5‐HT signalling and metabolism in human disease

Spiller, R. E. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00965.x · Cited by 164 · see citing works

Functional GI disorders: from animal models to drug development

Mayer, E. A., Bradesi, S., Chang, L., Spiegel, B. M. R., Bueller, J. A., & Naliboff, B. D. (2007) · Gut · doi:10.1136/gut.2006.101675 · Cited by 162 · see citing works

Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis

Nelson, A. D., Camilleri, M., Chirapongsathorn, S., Vijayvargiya, P., Valentin, N., Shin, A., Erwin, P. J., Wang, Z., & Murad, M. H. (2016) · Gut · doi:10.1136/gutjnl-2016-311835 · Cited by 159 · see citing works

Pharmacology of serotonin: what a clinician should know

Ponti, F. D. (2004) · Gut · doi:10.1136/gut.2003.035568 · Cited by 158 · see citing works

Constipation in Children: Novel Insight Into Epidemiology, Pathophysiology and Management

Rajindrajith, S., & Devanarayana, N. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.1.35 · Cited by 151 · see citing works

The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology

Sarosiek, I., Selover, K., KATZ, L. A., Semler, J. R., Wilding, G. E., Lackner, J. M., Sitrin, M. D., Kuo, B., Chey, W. D., Hasler, W. L., et al. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04162.x · Cited by 148 · see citing works

Irritable Bowel Syndrome

Ponti, F. D., & Tonini, M. (2001) · Drugs · doi:10.2165/00003495-200161030-00001 · Cited by 147 · see citing works

Constipation: evaluation and treatment of colonic and anorectal motility disorders.

Rao, S. S. C. (2007) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.07.013 · Cited by 84 · see citing works

Insights into the Pathophysiology and Mechanisms of Constipation, Irritable Bowel Syndrome, and Diverticulosis in Older People

Camilleri, M., Lee, J. S., Viramontes, B. E., Bharucha, A. E., & Tangalos, E. G. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04793.x · Cited by 144 · see citing works

Important role of mucosal serotonin in colonic propulsion and peristaltic reflexes: <i>in vitro</i> analyses in mice lacking tryptophan hydroxylase 1

Heredia, D. J., Gershon, M. D., Koh, S. D., Corrigan, R. D., Okamoto, T., & Smith, T. K. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.256230 · Cited by 144 · see citing works

Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort

manabe, N., wong, B. S., camilleri, M., burton, D., mckinzie, S., & zinsmeister, A. R. (2010) · Neurogastroenterology &amp; Motility · doi:10.1111/j.1365-2982.2009.01442.x · Cited by 142 · see citing works

Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis

Luthra, P., Camilleri, M., Burr, N. E., Quigley, E. M. M., Black, C. J., & Ford, A. C. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30246-8 · Cited by 140 · see citing works

Consensus report: clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome

Camilleri, M., Heading, R. C., & Thompson, W. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01305.x · Cited by 134 · see citing works

Expression and function of 5-HT 4 receptors in the mouse enteric nervous system

Liu, M., Geddis, M. S., Wen, Y., Setlik, W., & Gershon, M. D. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00245.2005 · Cited by 132 · see citing works

The therapy of constipation

Schiller, L. R. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00982.x · Cited by 131 · see citing works

Tegaserod, a 5‐HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects

Coffin, B., Farmachidi, J.-P., Rueegg, P. C., Bastie, A., & Bouhassira, D. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01449.x · Cited by 125 · see citing works

Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans

Manabe, N., Camilleri, M., Rao, A. S., Wong, B. S., Burton, D. B., Busciglio, I. A., Zinsmeister, A. R., & Haruma, K. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00043.2010 · Cited by 125 · see citing works

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

Evans, B. W., Clark, W. K., Moore, D., & Whorwell, P. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003960.pub3 · Cited by 125 · see citing works

Effect of Alvimopan and Codeine on Gastrointestinal Transit: A Randomized Controlled Study

Gonenne, J., Camilleri, M., Ferber, I. J., Burton, D. D., Baxter, K. L., Keyashian, K., Foss, J. F., Wallin, B., Du, W., & Zinsmeister, A. R. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00434-9 · Cited by 124 · see citing works

Serotonin pharmacology in the gastrointestinal tract: a review

Beattie, D. T., & Smith, J. A. M. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0276-9 · Cited by 121 · see citing works

Effect of renzapride on transit in constipation-predominant irritable bowel syndrome

Camilleri, M., McKinzie, S., Fox, J., Foxx–Orenstein, A. E., Burton, D. D., Thomforde, G. M., Baxter, K. L., & Zinsmeister, A. R. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00391-x · Cited by 118 · see citing works

Intestinal motility disturbances in intensive care patients pathogenesis and clinical impact

Fruhwald, S. M., Holzer, P. D., & Metzler, H. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0452-7 · Cited by 118 · see citing works

Irritable bowel syndrome subtypes according to bowel habit

Mearin, F., Balboa, A., Badia, X. C., Baró, E., Caldwell, E., Cucala, M., Díaz‐Rubio, M., Fueyo, A., Ponce, J. D. C., Roset, M., et al. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200302000-00010 · Cited by 114 · see citing works

Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?

Sweetser, S. R., Camilleri, M., Nord, S. L., Burton, D. D., Castenada, L., Croop, R. S., Tong, G., Dockens, R. C., & Zinsmeister, A. R. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00011.2009 · Cited by 114 · see citing works

Serotonin and colonic motility

Kendig, D. M., & Grider, J. R. (2015) · Neurogastroenterology &amp; Motility · doi:10.1111/nmo.12617 · Cited by 113 · see citing works

Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions

Deiteren, A., Camilleri, M., Bharucha, A. E., Burton, D. D., McKinzie, S., Rao, A. S., & Zinsmeister, A. R. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01441.x · Cited by 111 · see citing works

Plasticity in serotonin control mechanisms in the gut

Gershon, M. D. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.07.005 · Cited by 111 · see citing works

Economic Burden of Irritable Bowel Syndrome

Camilleri, M., & Williams, D. E. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017040-00003 · Cited by 109 · see citing works

The pharmacological treatment of acute colonic pseudo‐obstruction

GIORGIO, R. D., Barbara, G., Stanghellini, V., Tonini, M., Vasina, V. I., Cola, B., Corinaldesi, R., Biagi, G., & Ponti, F. D. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01088.x · Cited by 108 · see citing works

METHODS FOR THE ASSESSMENT OF SMALL BOWEL AND COLONIC TRANSIT

Szarka, L., & Camilleri, M. (2012) · Seminars in nuclear medicine · doi:10.1053/j.semnuclmed.2011.10.004 · Cited by 96 · see citing works

Review article: gastroparesis

PATRICK, A., & Epstein, O. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03637.x · Cited by 103 · see citing works

Effect of CCK-1 Antagonist, Dexloxiglumide, in Female Patients with Irritable Bowel Syndrome: A Pharmacodynamic and Pharmacogenomic Study

Cremonini, F., Camilleri, M., McKinzie, S., Carlson, P., Camilleri, C. E., Burton, D. D., Thomforde, G. M., Urrutia, R. A., & Zinsmeister, A. R. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41081.x · Cited by 103 · see citing works

Pharmacodynamic effects of a novel prokinetic 5‐HT4 receptor agonist, ATI‐7505, in humans

Camilleri, M., Vázquez-Roque, M., Burton, D., Ford, T. J., Mckinzie, S., Zinsmeister, A., & Druzgala, P. (2007) · Neurogastroenterology and Motility · doi:10.1111/j.1365-2982.2006.00865.x · Cited by 98 · see citing works

A dose‐ranging, placebo‐controlled, pilot trial of Acotiamide in patients with functional dyspepsia

Tack, J. F., Masclee, A., Heading, R. C., Berstad, A., Piessevaux, H. H., Popiela, T. J., Vandenberghe, A., & Kato, H. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01261.x · Cited by 101 · see citing works

Delayed Gastric Emptying in Gastroesophageal Reflux Disease: Reassessment with New Methods and Symptomatic Correlations

Buckles, D. C., Sarosiek, I., McCallum, R. W., & McMillin, C. (2004) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200401000-00001 · Cited by 101 · see citing works

New-generation 5-HT4receptor agonists: potential for treatment of gastrointestinal motility disorders

Manabe, N., Wong, B. S., & Camilleri, M. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.482927 · Cited by 97 · see citing works

Update on Gastrointestinal Scintigraphy

Maurer, A. H., & Parkman, H. P. (2006) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2005.12.003 · Cited by 97 · see citing works

Medical management of fecal incontinence

Scarlett, Y. V. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.10.007 · Cited by 97 · see citing works

Tegaserod for the treatment of irritable bowel syndrome

Evans, B., Clark, W., Moore, D., & Whorwell, P. J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003960.pub2 · Cited by 97 · see citing works

A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation

Bharucha, A. E., Low, P. A., Camilleri, M., Veil, E. B., Burton, D. D., Kudva, Y. C., Shah, P., Gehrking, T. L., & Zinsmeister, A. R. (2012) · Gut · doi:10.1136/gutjnl-2012-302483 · Cited by 95 · see citing works

The genetics of irritable bowel syndrome.

Saito, Y., Petersen, G., Locke, G., & Talley, N. J. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00184-9 · Cited by 42 · see citing works

Effect of tegaserod on gut transit in male and female subjects

Degen, L. P., Petrig, C., Studer, D., Schroller, S., & Beglinger, C. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00715.x · Cited by 89 · see citing works

Subject's Global Assessment of Relief: An appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials

Müller-Lissner, S. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00027-1 · Cited by 91 · see citing works

Serotonergic modulation of visceral sensation: lower gut

Camilleri, M. (2002) · Gut · doi:10.1136/gut.51.suppl_1.i81 · Cited by 90 · see citing works

Pharmacologic therapy for the irritable bowel syndrome

Talley, N. J. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07306.x · Cited by 89 · see citing works

Serotonin type‐4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum

Schikowski, A., Thewissen, M., Mathis, C., Ross, H., & Enck, P. (2002) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2002.00328.x · Cited by 88 · see citing works

Pathophysiology, Diagnosis, and Management of Chronic Intestinal Pseudo-Obstruction

Downes, T. J., Cheruvu, M. S., Karunaratne, T. B., GIORGIO, R. D., & Farmer, A. D. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001047 · Cited by 87 · see citing works

Irritable bowel syndrome

Talley, N. J. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01217.x · Cited by 86 · see citing works

Constipation: Evaluation and Treatment of Colonic and Anorectal Motility Disorders

Rao, S. S. C. (2009) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2008.12.006 · Cited by 79 · see citing works

Chronic constipation in children: Organic disorders are a major cause

Southwell, B. R., King, S. K., & Hutson, J. (2005) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2005.00527.x · Cited by 79 · see citing works

Pathophysiology as a basis for understanding symptom complexes and therapeutic targets

Camilleri, M., & Talley, N. J. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00516.x · Cited by 79 · see citing works

Irritable bowel syndrome in the 21st century: Perspectives from Asia or South‐east Asia

Chang, F., & Lu, C. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04672.x · Cited by 77 · see citing works

Alvimopan, a selective peripherally acting μ‐opioid antagonist*

Camilleri, M. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00640.x · Cited by 78 · see citing works

The SNMMI and EANM Practice Guideline for Small-Bowel and Colon Transit 1.0

Maurer, A. H., Camilleri, M., Donohoe, K. J., KNIGHT, L. C., Madsen, J. L., Mariani, G., Parkman, H. P., & Dolsen, J. V. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.129973 · Cited by 78 · see citing works

Spectrum of Gastroparesis in Children

Waseem, S., Islam, S., Kahn, G., Moshiree, B., & Talley, N. J. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31824cf06e · Cited by 78 · see citing works

Long‐term safety of tegaserod in patients with constipation‐predominant irritable bowel syndrome

Tougas, G. H., Snape, W. J., Otten, M. H., Earnest, D. L., Langaker, K. E., Pruitt, R. E., Pecher, E., Nault, B., & Rojavin, M. A. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01347.x · Cited by 78 · see citing works

A systematic review of tegaserod for the treatment of irritable bowel syndrome

Jones, B. W., Moore, D., Robinson, S., & Song, F. (2002) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2002.00426.x · Cited by 25 · see citing works

Effect of tegaserod on colonic transit time in male patients with constipation‐predominant irritable bowel syndrome

Harish, K., Hazeena, K., Thomas, V., Kumar, S., Jose, T., & Narayanan, P. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04543.x · Cited by 38 · see citing works

Tegaserod

Scott, L. J., & Perry, C. M. (1999) · Drugs · doi:10.2165/00003495-199958030-00013 · Cited by 49 · see citing works

Tegaserod, a 5‐HT 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects

Degen, L. P., Matzinger, D., Merz, M., Appel‐Dingemanse, S., Osborne, S., Lüchinger, S., Bertold, R., Maëcke, H. R., & Beglinger, C. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01103.x · Cited by 211 · see citing works

Does co‐administration of a non‐selective opiate antagonist enhance acceleration of transit by a 5‐HT4 agonist in constipation‐predominant irritable bowel syndrome? A randomized controlled trial

Foxx–Orenstein, A. E., Camilleri, M., Szarka, L. A., McKinzie, S., Burton, D. D., Thomforde, G. M., Baxter, K. L., & Zinsmeister, A. R. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.00944.x · Cited by 20 · see citing works